New: Evolving the Heatmap: Dow Jones, Nasdaq 100, Russell 2000, and More

Learn More
Last Close
Sep 18  •  04:00PM ET
67.22
Dollar change
+2.90
Percentage change
4.51
%
IndexS&P 500 P/E33.09 EPS (ttm)2.03 Insider Own0.66% Shs Outstand198.80M Perf Week-1.81%
Market Cap13.36B Forward P/E15.24 EPS next Y4.41 Insider Trans1.23% Shs Float197.50M Perf Month-9.19%
Enterprise Value15.72B PEG3.52 EPS next Q1.11 Inst Own102.49% Short Float3.33% Perf Quarter-3.71%
Income407.80M P/S3.30 EPS this Y10.90% Inst Trans0.98% Short Ratio2.42 Perf Half Y-16.10%
Sales4.05B P/B1.60 EPS next Y7.79% ROA3.33% Short Interest6.58M Perf YTD-26.88%
Book/sh42.02 P/C107.00 EPS next 5Y9.40% ROE5.01% 52W High112.29 -40.14% Perf Year-39.57%
Cash/sh0.63 P/FCF32.44 EPS past 3/5Y-49.03% -3.45% ROIC3.78% 52W Low61.78 8.81% Perf 3Y-12.01%
Dividend Est.0.01 (0.02%) EV/EBITDA14.15 Sales past 3/5Y10.05% 7.98% Gross Margin62.03% Volatility2.84% 2.84% Perf 5Y-17.73%
Dividend TTM- EV/Sales3.88 EPS Y/Y TTM12.94% Oper. Margin18.31% ATR (14)2.08 Perf 10Y80.98%
Dividend Ex-DateJul 26, 2023 Quick Ratio1.24 Sales Y/Y TTM6.35% Profit Margin10.08% RSI (14)45.52 Recom1.78
Dividend Gr. 3/5Y- - Current Ratio2.12 EPS Q/Q-5.82% SMA20-2.02% Beta1.02 Target Price83.29
Payout0.00% Debt/Eq0.30 Sales Q/Q5.73% SMA50-5.29% Rel Volume0.96 Prev Close64.32
Employees16000 LT Debt/Eq0.29 EarningsAug 27 AMC SMA200-17.22% Avg Volume2.71M Price67.22
IPOJan 21, 1983 Option/ShortYes / Yes EPS/Sales Surpr.3.23% -0.34% Trades Volume2,618,806 Change4.51%
Date Action Analyst Rating Change Price Target Change
Aug-28-25Downgrade Citigroup Buy → Neutral $72
Jul-22-25Upgrade BNP Paribas Exane Neutral → Outperform $92
Jun-17-25Upgrade Needham Hold → Buy $94
May-30-25Downgrade JP Morgan Overweight → Neutral $76
Aug-29-24Reiterated Piper Sandler Overweight $115 → $120
Jul-16-24Upgrade Jefferies Hold → Buy $107 → $115
Mar-19-24Upgrade Redburn Atlantic Neutral → Buy $125
Mar-13-24Upgrade JP Morgan Neutral → Overweight $100 → $120
Feb-06-24Resumed KeyBanc Capital Markets Sector Weight
Oct-30-23Initiated BofA Securities Buy $380
Today 11:42AM
Sep-17-25 04:15PM
Sep-15-25 09:40AM
Sep-09-25 12:02AM
Sep-03-25 01:31AM
03:30PM Loading…
Sep-02-25 03:30PM
Sep-01-25 09:15AM
Aug-31-25 11:34PM
Aug-29-25 09:47AM
09:40AM
Aug-28-25 05:28PM
04:25PM
04:05PM
11:48AM
11:30AM
11:20AM Loading…
11:20AM
11:12AM
09:50AM
09:39AM
05:46AM
05:10AM
03:06AM
Aug-27-25 06:00PM
05:25PM
04:49PM
04:15PM
Aug-26-25 06:42PM
11:40AM
09:55AM
08:22AM
11:02PM Loading…
Aug-25-25 11:02PM
09:51AM
Aug-22-25 09:15AM
Aug-20-25 10:00AM
Aug-19-25 08:50AM
Aug-14-25 05:30PM
04:15PM
Aug-12-25 10:58AM
08:13AM
Aug-11-25 08:28AM
Aug-07-25 07:40AM
Aug-06-25 05:25PM
Aug-05-25 12:16PM
12:00PM
11:40AM
07:36AM
12:00AM
Jul-31-25 08:50AM
Jul-25-25 07:55AM
Jul-24-25 04:15PM
Jul-22-25 11:56AM
Jul-14-25 06:20AM
Jul-02-25 08:21AM
Jul-01-25 01:32AM
Jun-23-25 11:31PM
09:32AM
Jun-19-25 11:20AM
Jun-18-25 09:51AM
Jun-07-25 09:47AM
Jun-05-25 05:37PM
Jun-03-25 09:45AM
Jun-02-25 09:40AM
09:15AM
08:43AM
May-30-25 08:47PM
02:13PM
12:41PM
11:59AM
11:40AM
09:32AM
03:08AM
May-29-25 09:10PM
06:00PM
05:30PM
04:51PM
04:30PM
04:15PM
09:29AM
May-28-25 03:03AM
May-23-25 09:15AM
May-22-25 09:18AM
May-20-25 04:15PM
07:48AM
May-15-25 06:35PM
May-14-25 11:40AM
07:47AM
May-12-25 07:33PM
May-08-25 04:15PM
07:10AM
12:36AM
May-07-25 05:45PM
May-06-25 09:45AM
May-01-25 07:55AM
Apr-30-25 04:15PM
Apr-29-25 04:15PM
Apr-21-25 10:40AM
Apr-17-25 11:17AM
Apr-03-25 07:36PM
05:04AM
Mar-24-25 07:30PM
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
White Albert G IIIPresident & CEOSep 05 '25Buy68.3910,000683,900226,151Sep 05 05:10 PM
Warner Gerard H IIIPresident, CooperVision, Inc.Sep 05 '25Buy69.231,450100,38418,319Sep 05 04:07 PM
McBride Daniel GEVP & Chief Operating OfficerSep 02 '25Buy65.043,000195,12063,120Sep 02 05:17 PM
Andrews Brian GEVP, CFO & TreasurerSep 02 '25Buy65.681,525100,16222,191Sep 02 05:16 PM
KOZY WILLIAM ADirectorApr 01 '25Option Exercise0.002,857031,149Apr 03 04:09 PM
WEISS ROBERT SDirectorApr 01 '25Option Exercise0.002,9930288,945Apr 03 04:09 PM
Rivas MariaDirectorApr 01 '25Option Exercise0.002,72102,721Apr 03 04:08 PM
MADDEN TERESA SDirectorApr 01 '25Option Exercise0.002,721012,357Apr 03 04:08 PM
Lucchese Cynthia LDirectorApr 01 '25Option Exercise0.002,72107,661Apr 03 04:07 PM
Kurzius Lawrence ErikDirectorApr 01 '25Option Exercise0.002,72103,777Apr 03 04:07 PM
Jay ColleenDirectorApr 01 '25Option Exercise0.002,721029,521Apr 03 04:06 PM
Ricupati AgostinoSVP & CAOApr 01 '25Option Exercise0.002,07609,044Apr 03 04:06 PM
McBride Daniel GEVP & Chief Operating OfficerFeb 01 '25Option Exercise0.0022,777071,687Feb 04 04:25 PM
White Albert G IIIPresident & CEOFeb 01 '25Option Exercise0.0084,2640258,941Feb 04 04:25 PM
Andrews Brian GEVP, CFO & TreasurerFeb 01 '25Option Exercise0.0016,850023,464Feb 04 04:24 PM
Sheffield Holly RPresident, CSIFeb 01 '25Option Exercise0.0017,309045,843Feb 04 04:24 PM
White Albert G IIIPresident & CEOJan 08 '25Option Exercise0.0018,3400183,613Jan 10 04:12 PM
Warner Gerard H IIIPresident, CooperVision, Inc.Jan 08 '25Option Exercise0.0013,328023,763Jan 10 04:12 PM
Sheffield Holly RPresident, CSIJan 08 '25Option Exercise0.004,900030,898Jan 10 04:11 PM
Ricupati AgostinoSVP & CAOJan 08 '25Option Exercise0.004,47209,328Jan 10 04:11 PM
McBride Daniel GEVP & Chief Operating OfficerJan 08 '25Option Exercise0.008,728053,424Jan 10 04:11 PM
Andrews Brian GEVP, CFO & TreasurerJan 08 '25Option Exercise0.006,420013,034Jan 10 04:10 PM
Khadder NicholasVP, General Counsel & Corp SecJan 08 '25Option Exercise0.003,49204,369Jan 10 04:10 PM
White Albert G IIIPresident & CEOSep 19 '24Option Exercise43.83114,9925,040,099280,265Sep 20 05:51 PM
White Albert G IIIPresident & CEOSep 19 '24Sale110.53114,99212,710,041165,273Sep 20 05:51 PM
Albert G. White IIIOfficerSep 19 '24Proposed Sale110.53114,99212,709,660Sep 19 03:53 PM
Last Close
Sep 18  •  04:00PM ET
31.80
Dollar change
+0.62
Percentage change
1.99
%
OMCL Omnicell, Inc daily Stock Chart
IndexRUT P/E64.46 EPS (ttm)0.49 Insider Own3.31% Shs Outstand46.42M Perf Week-4.45%
Market Cap1.46B Forward P/E18.77 EPS next Y1.69 Insider Trans0.44% Shs Float44.41M Perf Month-0.34%
Enterprise Value1.41B PEG11.41 EPS next Q0.36 Inst Own104.39% Short Float4.36% Perf Quarter12.49%
Income23.09M P/S1.27 EPS this Y-9.28% Inst Trans-0.10% Short Ratio3.73 Perf Half Y-8.36%
Sales1.15B P/B1.17 EPS next Y9.19% ROA1.04% Short Interest1.94M Perf YTD-28.57%
Book/sh27.22 P/C3.39 EPS next 5Y5.65% ROE1.87% 52W High55.74 -42.95% Perf Year-29.13%
Cash/sh9.39 P/FCF13.67 EPS past 3/5Y-44.95% -28.29% ROIC1.58% 52W Low22.66 40.34% Perf 3Y-67.59%
Dividend Est.- EV/EBITDA13.50 Sales past 3/5Y-0.59% 4.39% Gross Margin43.88% Volatility3.27% 2.99% Perf 5Y-55.75%
Dividend TTM- EV/Sales1.23 EPS Y/Y TTM209.58% Oper. Margin1.52% ATR (14)1.01 Perf 10Y-6.14%
Dividend Ex-Date- Quick Ratio1.22 Sales Y/Y TTM6.39% Profit Margin2.01% RSI (14)49.23 Recom1.75
Dividend Gr. 3/5Y- - Current Ratio1.40 EPS Q/Q47.97% SMA20-2.18% Beta0.89 Target Price44.00
Payout0.00% Debt/Eq0.30 Sales Q/Q4.98% SMA503.11% Rel Volume1.98 Prev Close31.18
Employees3670 LT Debt/Eq0.16 EarningsJul 31 BMO SMA200-8.54% Avg Volume519.87K Price31.80
IPOAug 07, 2001 Option/ShortYes / Yes EPS/Sales Surpr.66.67% 5.56% Trades Volume1,030,796 Change1.99%
Date Action Analyst Rating Change Price Target Change
May-14-25Upgrade Wells Fargo Equal Weight → Overweight $35
Oct-31-24Downgrade BofA Securities Buy → Neutral $44 → $57
Aug-02-24Upgrade Barclays Underweight → Equal Weight $26 → $39
Jan-03-24Initiated Barclays Underweight $33
Nov-03-23Upgrade Wells Fargo Underweight → Equal Weight $39 → $28
Nov-03-23Upgrade Piper Sandler Neutral → Overweight $70 → $39
Nov-03-23Downgrade BTIG Research Buy → Neutral
Oct-11-23Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Sep-26-23Reiterated Wells Fargo Underweight $56 → $39
Aug-02-23Downgrade Piper Sandler Overweight → Neutral $66 → $70
Today 09:40AM
Sep-15-25 11:40AM
Sep-12-25 03:35AM
Sep-11-25 03:00PM
09:55AM
12:34AM Loading…
Sep-05-25 12:34AM
Sep-03-25 11:30AM
Sep-01-25 12:02AM
Aug-27-25 11:38PM
Aug-26-25 12:20PM
09:55AM
Aug-25-25 04:05PM
Aug-14-25 09:34AM
Aug-13-25 12:04AM
Aug-12-25 11:50PM
09:55AM Loading…
Aug-01-25 09:55AM
Jul-31-25 07:45AM
06:59AM
06:43AM
06:30AM
Jul-30-25 01:09PM
11:40AM
Jul-29-25 11:04PM
Jul-28-25 10:00AM
Jul-24-25 10:00AM
08:00AM
12:33AM
Jul-21-25 12:20PM
Jul-18-25 08:34AM
Jul-15-25 04:05PM
04:01PM Loading…
Jul-14-25 04:01PM
Jul-09-25 12:13PM
Jul-07-25 12:01AM
Jul-03-25 04:08AM
Jun-26-25 05:58PM
Jun-16-25 11:38PM
Jun-13-25 08:42AM
Jun-06-25 09:02AM
Jun-05-25 11:31AM
May-31-25 05:59AM
May-22-25 01:25PM
08:30AM
May-19-25 08:33AM
May-15-25 08:55AM
May-14-25 04:01PM
08:30AM
May-07-25 01:25PM
09:20AM
03:07AM
01:35AM
May-06-25 07:40AM
06:43AM
06:30AM
May-02-25 10:56AM
Apr-29-25 05:06AM
Apr-28-25 09:40AM
05:04AM
Apr-27-25 01:09PM
Apr-22-25 07:29AM
Apr-14-25 04:01PM
Apr-10-25 05:08PM
09:40AM
Apr-08-25 05:12AM
Mar-25-25 09:40AM
Mar-24-25 04:01PM
Mar-12-25 08:30AM
Feb-28-25 08:02AM
Feb-24-25 12:00PM
Feb-11-25 09:55AM
Feb-07-25 02:11AM
Feb-06-25 07:45AM
07:06AM
06:55AM
06:30AM
Feb-05-25 08:11AM
Jan-13-25 05:47PM
Jan-08-25 04:01PM
Dec-18-24 12:20PM
Dec-12-24 12:00PM
Dec-09-24 08:30AM
Nov-29-24 11:31AM
Nov-22-24 04:01PM
Nov-21-24 09:55AM
Nov-20-24 02:00AM
Nov-18-24 04:12PM
Nov-06-24 12:20PM
Oct-31-24 09:15AM
07:00AM
Oct-30-24 04:25PM
07:45AM
06:41AM
06:30AM
Oct-11-24 12:14PM
Oct-07-24 05:35PM
Oct-04-24 12:00PM
Sep-25-24 04:01PM
Aug-28-24 12:20PM
Aug-21-24 09:04AM
Aug-20-24 04:30PM
Aug-15-24 04:01PM
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERSep 12 '25Sale33.253,880129,010110,653Sep 16 04:09 PM
Manley Corey JOfficerSep 12 '25Proposed Sale33.253,880129,010Sep 12 11:36 AM
LIPPS RANDALL ACHAIRMAN, PRESIDENT AND CEOMar 14 '25Buy33.1310,561349,874333,610Mar 18 04:13 PM
PARRISH MARK WDirectorDec 10 '24Sale47.3012,000567,63858,427Dec 12 04:03 PM
PARRISH MARK WDirectorDec 10 '24Proposed Sale46.0012,000552,000Dec 10 04:51 PM